
Valarie E. Bertoglio
Examiner (ID: 15710, Phone: (571)272-0725 , Office: P/1632 )
| Most Active Art Unit | 1632 |
| Art Unit(s) | 1632 |
| Total Applications | 1314 |
| Issued Applications | 630 |
| Pending Applications | 181 |
| Abandoned Applications | 515 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 17505496
[patent_doc_number] => 20220098598
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-03-31
[patent_title] => METHODS FOR MODIFYING THE GROWTH RATE OF A CELL
[patent_app_type] => utility
[patent_app_number] => 17/552720
[patent_app_country] => US
[patent_app_date] => 2021-12-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16700
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 61
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17552720
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/552720 | METHODS FOR MODIFYING THE GROWTH RATE OF A CELL | Dec 15, 2021 | Pending |
Array
(
[id] => 18970432
[patent_doc_number] => 20240050524
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-02-15
[patent_title] => DELIVERY OF ABETA VARIANTS FOR AGGREGATION INHIBITION
[patent_app_type] => utility
[patent_app_number] => 18/267980
[patent_app_country] => US
[patent_app_date] => 2021-12-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 48299
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18267980
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/267980 | DELIVERY OF ABETA VARIANTS FOR AGGREGATION INHIBITION | Dec 14, 2021 | Pending |
Array
(
[id] => 17519304
[patent_doc_number] => 20220105152
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-04-07
[patent_title] => Composition for and Method of Treating Hepatic Tissue Injury
[patent_app_type] => utility
[patent_app_number] => 17/549105
[patent_app_country] => US
[patent_app_date] => 2021-12-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10546
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17549105
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/549105 | Composition for and Method of Treating Hepatic Tissue Injury | Dec 12, 2021 | Abandoned |
Array
(
[id] => 17480633
[patent_doc_number] => 20220088137
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-03-24
[patent_title] => METHODS FOR DETECTING AND MODULATING THE EMBRYONIC-FETAL TRANSITION IN MAMMALIAN SPECIES
[patent_app_type] => utility
[patent_app_number] => 17/542997
[patent_app_country] => US
[patent_app_date] => 2021-12-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 37592
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17542997
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/542997 | METHODS FOR DETECTING AND MODULATING THE EMBRYONIC-FETAL TRANSITION IN MAMMALIAN SPECIES | Dec 5, 2021 | Abandoned |
Array
(
[id] => 17625818
[patent_doc_number] => 20220160833
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-05-26
[patent_title] => METHODS FOR DETECTING AND MODULATING THE EMBRYONIC-FETAL TRANSITION IN MAMMALIAN SPECIES
[patent_app_type] => utility
[patent_app_number] => 17/542992
[patent_app_country] => US
[patent_app_date] => 2021-12-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 37593
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -26
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17542992
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/542992 | METHODS FOR DETECTING AND MODULATING THE EMBRYONIC-FETAL TRANSITION IN MAMMALIAN SPECIES | Dec 5, 2021 | Pending |
Array
(
[id] => 17480634
[patent_doc_number] => 20220088138
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-03-24
[patent_title] => METHODS FOR DETECTING AND MODULATING THE EMBRYONIC-FETAL TRANSITION IN MAMMALIAN SPECIES
[patent_app_type] => utility
[patent_app_number] => 17/543020
[patent_app_country] => US
[patent_app_date] => 2021-12-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 37591
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17543020
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/543020 | METHODS FOR DETECTING AND MODULATING THE EMBRYONIC-FETAL TRANSITION IN MAMMALIAN SPECIES | Dec 5, 2021 | Abandoned |
Array
(
[id] => 17460570
[patent_doc_number] => 20220073875
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-03-10
[patent_title] => Amplifiable RNAs for Therapeutic Cell Systems
[patent_app_type] => utility
[patent_app_number] => 17/529686
[patent_app_country] => US
[patent_app_date] => 2021-11-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 35656
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -70
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17529686
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/529686 | Amplifiable RNAs for Therapeutic Cell Systems | Nov 17, 2021 | Abandoned |
Array
(
[id] => 17457880
[patent_doc_number] => 20220071184
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-03-10
[patent_title] => RED TRANSGENIC FLUORESCENT ORNAMENTAL FISH
[patent_app_type] => utility
[patent_app_number] => 17/528936
[patent_app_country] => US
[patent_app_date] => 2021-11-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2831
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17528936
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/528936 | Red transgenic fluorescent ornamental fish | Nov 16, 2021 | Issued |
Array
(
[id] => 17911325
[patent_doc_number] => 20220313720
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-10-06
[patent_title] => TARGETED CANCER THERAPY
[patent_app_type] => utility
[patent_app_number] => 17/528827
[patent_app_country] => US
[patent_app_date] => 2021-11-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12379
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17528827
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/528827 | TARGETED CANCER THERAPY | Nov 16, 2021 | Abandoned |
Array
(
[id] => 17400005
[patent_doc_number] => 20220042095
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-02-10
[patent_title] => METHODS AND COMPOSITIONS FOR MONITORING AND ENHANCING EARLY EMBRYO DEVELOPMENT
[patent_app_type] => utility
[patent_app_number] => 17/511092
[patent_app_country] => US
[patent_app_date] => 2021-10-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11050
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 119
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17511092
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/511092 | METHODS AND COMPOSITIONS FOR MONITORING AND ENHANCING EARLY EMBRYO DEVELOPMENT | Oct 25, 2021 | Abandoned |
Array
(
[id] => 17385995
[patent_doc_number] => 20220033847
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-02-03
[patent_title] => NON-HUMAN ANIMALS EXPRESSING HUMANIZED C1Q COMPLEX
[patent_app_type] => utility
[patent_app_number] => 17/506730
[patent_app_country] => US
[patent_app_date] => 2021-10-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 31952
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -86
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17506730
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/506730 | NON-HUMAN ANIMALS EXPRESSING HUMANIZED C1Q COMPLEX | Oct 20, 2021 | Abandoned |
Array
(
[id] => 18808614
[patent_doc_number] => 20230382948
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-11-30
[patent_title] => DELIVERY OF ENDOTHELIAL CELL-LADEN MICROGEL ELICITS ANGIOGENESIS IN SELF-ASSEMBLING ULTRASHORT PEPTIDE HYDROGELS
[patent_app_type] => utility
[patent_app_number] => 18/032351
[patent_app_country] => US
[patent_app_date] => 2021-10-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17111
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18032351
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/032351 | DELIVERY OF ENDOTHELIAL CELL-LADEN MICROGEL ELICITS ANGIOGENESIS IN SELF-ASSEMBLING ULTRASHORT PEPTIDE HYDROGELS | Oct 19, 2021 | Pending |
Array
(
[id] => 20402412
[patent_doc_number] => 12492382
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-12-09
[patent_title] => Blood type O Rh--hypo-immunogenic cells
[patent_app_type] => utility
[patent_app_number] => 17/504502
[patent_app_country] => US
[patent_app_date] => 2021-10-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 16459
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 137
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17504502
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/504502 | Blood type O Rh--hypo-immunogenic cells | Oct 18, 2021 | Issued |
Array
(
[id] => 17657385
[patent_doc_number] => 20220177850
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-09
[patent_title] => METHODS FOR GENERATING STEM CELL-DERIVED BETA CELLS AND METHODS OF USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/503143
[patent_app_country] => US
[patent_app_date] => 2021-10-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8159
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17503143
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/503143 | Methods for generating stem cell-derived b cells and methods of use thereof | Oct 14, 2021 | Issued |
Array
(
[id] => 17354546
[patent_doc_number] => 20220015342
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-01-20
[patent_title] => GENE EDITING OF REPRODUCTIVE HORMONES TO REDUCE FERTILITY IN ICTALURUS PUNCTATUS
[patent_app_type] => utility
[patent_app_number] => 17/498110
[patent_app_country] => US
[patent_app_date] => 2021-10-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19127
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17498110
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/498110 | GENE EDITING OF REPRODUCTIVE HORMONES TO REDUCE FERTILITY IN ICTALURUS PUNCTATUS | Oct 10, 2021 | Abandoned |
Array
(
[id] => 17385918
[patent_doc_number] => 20220033770
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-02-03
[patent_title] => MACS-BASED PURIFICATION OF STEM CELL-DERIVED RETINAL PIGMENT EPITHELIUM
[patent_app_type] => utility
[patent_app_number] => 17/493533
[patent_app_country] => US
[patent_app_date] => 2021-10-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21052
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 75
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17493533
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/493533 | Macs-based purification of stem cell-derived retinal pigment epithelium | Oct 3, 2021 | Issued |
Array
(
[id] => 17457881
[patent_doc_number] => 20220071185
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-03-10
[patent_title] => GENETICALLY MODIFIED NON-HUMAN ANIMAL WITH HUMAN OR CHIMERIC CD137
[patent_app_type] => utility
[patent_app_number] => 17/482991
[patent_app_country] => US
[patent_app_date] => 2021-09-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22239
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17482991
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/482991 | GENETICALLY MODIFIED NON-HUMAN ANIMAL WITH HUMAN OR CHIMERIC CD137 | Sep 22, 2021 | Abandoned |
Array
(
[id] => 19381218
[patent_doc_number] => 20240271088
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-08-15
[patent_title] => METHOD FOR MAINTAINING AND AMPLIFYING HUMAN PRIMORDIAL GERM CELLS / HUMAN PRIMORDIAL GERM CELL-LIKE CELLS
[patent_app_type] => utility
[patent_app_number] => 18/042134
[patent_app_country] => US
[patent_app_date] => 2021-08-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 28830
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18042134
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/042134 | METHOD FOR MAINTAINING AND AMPLIFYING HUMAN PRIMORDIAL GERM CELLS / HUMAN PRIMORDIAL GERM CELL-LIKE CELLS | Aug 16, 2021 | Pending |
Array
(
[id] => 17688099
[patent_doc_number] => 20220195391
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-23
[patent_title] => PLATELET-RICH PLASMA COMPOSITIONS AND METHODS OF PREPARATION
[patent_app_type] => utility
[patent_app_number] => 17/444009
[patent_app_country] => US
[patent_app_date] => 2021-07-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11535
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 37
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17444009
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/444009 | PLATELET-RICH PLASMA COMPOSITIONS AND METHODS OF PREPARATION | Jul 28, 2021 | Abandoned |
Array
(
[id] => 20881282
[patent_doc_number] => 12697301
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2026-08-04
[patent_title] => Pulmonary delivery of mRNA to non-lung target cells
[patent_app_type] => utility
[patent_app_number] => 17/389016
[patent_app_country] => US
[patent_app_date] => 2021-07-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 20
[patent_no_of_words] => 23557
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 87
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17389016
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/389016 | Pulmonary Delivery of MRNA to Non-lung Target Cells | Jul 28, 2021 | Pending |